Acquisition of Enzalutamide 40mg Phase 1-Third Quarter 2026

By: Hospital de Clinicas๐Ÿ“ BoliviaOpen

Key Information

ReferenceGB-26-0902-21-1704974-1-1
DeadlineNov 13, 2026 12:00 AM
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryBolivia
AddressBolivia
PublishedNov 3, 2026

Description

Acquisition of Enzalutamide 40mg Phase 1-Third Quarter 2026

Full details are available after unlocking this tender.